User profiles for J.-C. Lagier
Jean-Christophe LagierAix Marseille Université, IRD, MEPHI, APHM, IHU Méditerranée Infection Verified email at univ-amu.fr Cited by 28663 |
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
P Gautret, JC Lagier, P Parola, L Meddeb… - International journal of …, 2020 - Elsevier
Background Chloroquine and hydroxychloroquine have been found to be efficient on SARS-CoV-2,
and reported to be efficient in Chinese COV-19 patients. We evaluate the effect of …
and reported to be efficient in Chinese COV-19 patients. We evaluate the effect of …
[HTML][HTML] Microbial culturomics: paradigm shift in the human gut microbiome study
Comprehensive determination of the microbial composition of the gut microbiota and the
relationships with health and disease are major challenges in the 21st century. Metagenomic …
relationships with health and disease are major challenges in the 21st century. Metagenomic …
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot …
P Gautret, JC Lagier, P Parola, L Meddeb… - Travel medicine and …, 2020 - Elsevier
Background We need an effective treatment to cure COVID-19 patients and to decrease
virus carriage duration. Methods We conducted an uncontrolled, non-comparative, …
virus carriage duration. Methods We conducted an uncontrolled, non-comparative, …
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: a retrospective analysis of 1061 cases in Marseille, France
Background In France, the combination hydroxychloroquine (HCQ) and azithromycin (AZ) is
used in the treatment of COVID-19. Methods We retrospectively report on 1061 SARS-CoV-…
used in the treatment of COVID-19. Methods We retrospectively report on 1061 SARS-CoV-…
[PDF][PDF] Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Repositioning of drugs to use as antiviral treatment is a critical need [1]. It is commonly very
26 badly perceived by virologists, as we experienced this in reporting the effectiveness of 27 …
26 badly perceived by virologists, as we experienced this in reporting the effectiveness of 27 …
Culture of previously uncultured members of the human gut microbiota by culturomics
Metagenomics revolutionized the understanding of the relations among the human microbiome,
health and diseases, but generated a countless number of sequences that have not …
health and diseases, but generated a countless number of sequences that have not …
The rebirth of culture in microbiology through the example of culturomics to study human gut microbiota
JC Lagier, P Hugon, S Khelaifia… - Clinical microbiology …, 2015 - Am Soc Microbiol
Bacterial culture was the first method used to describe the human microbiota, but this method
is considered outdated by many researchers. Metagenomics studies have since been …
is considered outdated by many researchers. Metagenomics studies have since been …
Culturing the human microbiota and culturomics
The gut microbiota has an important role in the maintenance of human health and in disease
pathogenesis. This importance was realized through the advent of omics technologies and …
pathogenesis. This importance was realized through the advent of omics technologies and …
Current and past strategies for bacterial culture in clinical microbiology
JC Lagier, S Edouard, I Pagnier… - Clinical microbiology …, 2015 - Am Soc Microbiol
A pure bacterial culture remains essential for the study of its virulence, its antibiotic
susceptibility, and its genome sequence in order to facilitate the understanding and treatment of …
susceptibility, and its genome sequence in order to facilitate the understanding and treatment of …
Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths
…, A Belot, K Saker, P Garçon, JG Rivière, JC Lagier… - Science …, 2021 - science.org
Circulating autoantibodies (auto-Abs) neutralizing high concentrations (10 ng/ml; in plasma
diluted 1:10) of IFN-α and/or IFN-ω are found in about 10% of patients with critical COVID-19 …
diluted 1:10) of IFN-α and/or IFN-ω are found in about 10% of patients with critical COVID-19 …